ProfileGDS5822 / ILMN_1236938
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 54% 19% 57% 19% 51% 54% 30% 15% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 123.954
GSM1276600PDAC Late Ablation Control 214.519
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 123.557
GSM1276603PDAC Late Ablation 211.619
GSM1276604PDAC Late Ablation 324.951
GSM1303940PDAC Late Ablation_anti-CTLA4 124.254
GSM1303941PDAC Late Ablation_anti-CTLA4 214.730
GSM1303942PDAC Late Ablation_anti-CTLA4 38.715